• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR); CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR); CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221283
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/06/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported that while using bd bbl¿ trypticase¿ soy agar (soybean-casein digest agar) atypical growth was observed by the laboratory personnel.Here was no indication that results were reported out and there was no report of patient impact.The following information was provided by the initial reporter: "it was reported that growth promotion issues.".
 
Additional Manufacturer Narrative
This mdr should be considered cancelled.It was determined that this was a quality control issue.Erroneous results during quality control would be suspected and lead to retesting.
 
Event or Problem Description
It was reported that while using bd bbl¿ trypticase¿ soy agar (soybean-casein digest agar) atypical growth was observed by the laboratory personnel.Here was no indication that results were reported out and there was no report of patient impact.The following information was provided by the initial reporter: " it was reported that growth promotion issues.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR)
Common Device Name
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key12271462
Report Number1119779-2021-01281
Device Sequence Number17264757
Product Code JSG
UDI-Device Identifier10382902212833
UDI-Public10382902212833
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
PREAMENDMENT
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source other,user facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date09/23/2021
Device Model Number221283
Device Catalogue Number221283
Device Lot Number1152676
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 07/07/2021
Supplement Date Received by Manufacturer09/07/2021
Initial Report FDA Received Date08/03/2021
Supplement Report FDA Received Date09/10/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-